FDA Grants Fast Track Approval For Sleep Apnea Latest Drug AD109
The pharmaceutical company Apnimed has recently announced receiving Fast Track designation from the US Food and Drug Administration (FDA) for AD109, a novel oral drug for the treatment of obstructive sleep apnea (OSA). The fast…